Gut microbiome research is one of the more genuinely exciting areas in metabolic science, and it is being marketed several years ahead of what the evidence supports. This page separates the two — what the research establishes, what it does not, and the safety exclusions that matter for live bacterial products.
The Observation Driving the Category
The starting point is real and reasonably well replicated: the composition of gut bacterial populations differs between people with and without obesity and metabolic disease. Certain organisms — Akkermansia muciniphila most prominently — are consistently found at lower abundance in people with metabolic dysfunction.
The gap between that and a product claim is large. An association does not tell you which direction causation runs. Lower Akkermansia might contribute to metabolic dysfunction, or metabolic dysfunction and the diet accompanying it might reduce Akkermansia, or both might follow from something else. Observational data cannot settle this.
The Akkermansia Evidence, Stated Accurately
The study almost every Akkermansia product alludes to is Depommier and colleagues, published in Nature Medicine in 2019. It gave pasteurized Akkermansia muciniphila to overweight and obese volunteers over three months and reported improvements in insulin sensitivity and several metabolic markers.
Three things about that study are worth holding together at once:
- It is real and it is good work, published in a serious journal.
- It involved roughly 32 participants over three months — a pilot.
- Its own authors describe it as a proof-of-concept exploratory study. That is the correct characterisation, and marketing that presents it as established efficacy is overstating it.
Pilot studies exist to establish feasibility and justify larger trials. What would move this from interesting to established is a larger, longer, independently replicated randomized trial. That is a reasonable thing to wait for before spending significantly.
Why Strain Specificity Matters
This is the technical point that makes most probiotic labels hard to evaluate. Probiotic effects are documented for specific strains — identified by a designation after the species name — not for species as a whole.
A trial showing an effect for one strain of Bifidobacterium tells you essentially nothing about a different strain of the same species. Yet most product labels in the GLP-1 supplement category name species only, and several give a single combined milligram figure for a multi-strain blend rather than amounts per strain.
The practical consequence: if a label does not identify strains and amounts, you cannot check the product against any published research, however good that research is. Our label guide covers what to look for.
Reading CFU and AFU Counts
Two counting conventions appear on probiotic labels, and they are not interchangeable.
- CFU — colony forming units. Counted by culturing the product and counting colonies that grow. The traditional standard.
- AFU — active fluorescent units. Counted by flow cytometry, which detects cells including those that are viable but difficult to culture. Often produces higher numbers than CFU for the same product.
Because AFU counts tend to be higher, comparing an AFU figure on one product against a CFU figure on another is not a like-for-like comparison. Note also that higher is not automatically better — the appropriate count depends entirely on the strain and the intended effect. Akkermansia products typically use far lower counts than lactobacillus-based general probiotics.
What This Evidence Cannot Support
- Weight loss claims. No probiotic has demonstrated the weight outcomes prescription GLP-1s produce, and none may legally claim to treat obesity.
- Claims about a finished product based on ingredient research. Product-level trials in this category are rare to nonexistent.
- Transfer between strains. Research on one strain does not support claims for another.
- Durable microbiome change. Whether swallowed bacteria establish lasting colonisation is itself an open question.
Who Should Not Take Live Probiotics
Probiotics are generally well tolerated by healthy people, but they are live organisms and are not appropriate for everyone. Documented risks exist for:
- People who are severely immunocompromised
- People with an active C. difficile infection or recent IV antibiotic use
- People with central venous catheters
- Critically ill patients
- Pregnant and breastfeeding people, and anyone under 18, without advice
A manufacturer that publishes these exclusions is behaving responsibly. Among the products we reviewed, CoreAge Rx publishes them explicitly. It is worth checking whether the product you are considering does — see our guide to when to involve a professional.
One practical note: live-culture products often require refrigeration and cold-chain shipping. A product shipped ambient in summer with no temperature control is worth asking about.
Frequently Asked Questions
What did the Akkermansia muciniphila study actually find?
A proof-of-concept exploratory study published in Nature Medicine in 2019 gave pasteurized Akkermansia muciniphila to approximately 32 overweight and obese volunteers over three months and reported improvements in insulin sensitivity and some metabolic markers. The authors describe it as exploratory. It is a real finding in a serious journal, and it is one small pilot study.
Why does strain specificity matter?
Probiotic effects are documented at the strain level, not the species level. A result for one strain does not transfer to a different strain of the same species. This is why labels that name only species — without strain designations or amounts — give you very little you can check against the literature.
What is the difference between CFU and AFU?
CFU means colony forming units, counted by growing colonies on a plate. AFU means active fluorescent units, counted by flow cytometry, which includes cells that are viable but difficult to culture. AFU counts are often higher than CFU counts for the same product, so the two numbers are not directly comparable across products.
Do probiotics cause weight loss?
The evidence does not support that claim. Observational research consistently finds microbiome differences between people with and without obesity, but that does not establish causation or direction. Intervention trials are mostly small, short and strain-specific, and results do not generalise across products.
Who should avoid live probiotics?
People who are severely immunocompromised, have an active C. difficile infection or recent IV antibiotic use, have central venous catheters, or are critically ill. Live bacterial products carry documented infection risk in these groups. Pregnant and breastfeeding people and anyone under 18 should seek advice first.
Sources
- Depommier et al., "Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study," Nature Medicine, 2019.
- Research on gut microbiome composition differences associated with obesity and metabolic syndrome.
- International Scientific Association for Probiotics and Prebiotics — consensus statements on probiotic definitions and strain specificity.
- Published safety literature on probiotic-associated infection risk in immunocompromised and critically ill patients.
- US Food & Drug Administration — Dietary Supplements regulation and permitted claims.
Supplement Disclaimer & Review Date
These statements have not been evaluated by the Food and Drug Administration. Dietary supplements are not intended to diagnose, treat, cure, or prevent any disease. Dietary supplements are not FDA-approved medications, are not reviewed by the FDA for safety or effectiveness before they go on sale, and are not a substitute for prescription treatment.
Nothing on this page is medical advice, and nothing here should be read as a promise of weight loss or of any particular result. Supplements can interact with prescription medications and are not appropriate for everyone. Talk to a doctor or pharmacist who knows your medical history before starting any supplement — particularly if you are pregnant or breastfeeding, take prescription medication, manage a chronic condition, or are already taking a GLP-1 medication.
Product details come from the manufacturer's own published materials as of the date below. Ingredients, amounts, pricing, and policies change frequently — check the current label and product page before purchasing.
Last reviewed: August 5, 2026
Related Reading
Best Probiotics for Weight Management
Products ranked, with safety exclusions stated.
How to Read a Supplement Label
Strains, counts, and proprietary blends.
Best GLP-1 Supplements
The overlapping category, with placement disclosed.
When to Talk to a Professional
The conditions that rule out live probiotics.